A team of researchers from the University of Toronto, led by Zafiris J. Daskalakis, M.D., Ph.D., FRCP(C), three-time NARSAD Grantee and Associate Professor in the Department of Psychiatry, recently discovered that...
- Mental Illnesses
- Discoveries
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are here
Mental Illnesses ›Schizophrenia
Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research
Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.
Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.
Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.
NARSAD Distinguished Investigator Grantee, Martin Schalling, M.D., Ph.D. was among a team of researchers from the Karolinska Institutet in Sweden who recently discovered a genetic variant of an enzyme in the brain that...
In a new imaging-genetics study, NARSAD Grantees have uncovered a single gene that may explain dramatic differences among people with schizophrenia. The study, led by NARSAD Grantees, Aristotle Voineskos, M.D., Ph.D.,...
WOMEN’S MENTAL HEALTH CONFERENCE: THE ART & SCIENCE OF CARING
On September 14, 2012 the Brain & Behavior Research Foundation hosted a Women’s Mental Health Conference: The Art & Science of Caring in...
A recent study, led in part by NARSAD Young Investigator Grantee Debra Titone, Ph.D. at McGill University, indicates that patients with schizophrenia are likely to have problems with reading fluency. This discovery may...
Pages
Stories of recovery
Meet our scientists
Ask an Expert
|
To date the Brain & Behavior Research Foundation has provided 2,153 grants worth $140,731,742 to researchers focused on schizophrenia and related mental illnesses. |
DONATE NOW |














